Chana Greenberg has 20 years’ experience in the start-up and innovation space. She was business development lead at the Centre for Medicinal Cannabis from early 2019 and was most recently VP Business Development at a Canadian LP to build the supply chain of their API licensed CBD for the pharmaceutical (human and veterinary), athletic and health and wellness markets. Chana is passionate about promoting the knowledge of the benefits of cannabis-based products to improve health and wellbeing.
Before transitioning to the medical cannabis industry, Chana worked in traditional investment banking at Barclays and JP Morgan to Buttonwood Capital, a hedge fund founded by a former Goldman Sachs partner, where she researched artificial spinal discs and dental implants. She was until recently Vice Chair of Hadassah UK, supporting Hadassah Hospital, Jerusalem, which shares a campus with the Hebrew University, both pioneers in medicinal cannabis for over 60 years.
Chana holds a BA (Hons) in Business Studies from the University of Westminster, an MPhil in Finance from the University of Cambridge and completed SAID Business School's Private Equity Program at the University of Oxford.